Diabetes

September 03, 2020

At recommended adherence rates, automatic AI screening technology for diabetic retinopathy is a preferred strategy over conventional eye care professional screening.

September 02, 2020

For patients without diabetes, low serum bicarbonate and higher high sensitivity troponin T, NTproBNP, and urine NGAL were linked to a higher risk of the composite outcome.

September 01, 2020

Investigators report on a post-hoc analysis of the EMPA-REG OUTCOME trial that assesses the efficacy of the SGLT-2 inhibitor in patients with obstructive sleep apnea.

September 01, 2020

The new equation model has shown to be more accurate than the Framingham Lifetime Risk equation and Pooled Cohort Equation.

August 31, 2020

New data shows that high BMI individuals who were in the lowest polygenic score quintile had a 5-fold greater risk of diabetes than those with low BMI and a high polygenic score.

August 30, 2020

Dapagliflozin and empagliflozin are shown to minimize CV events in patients with heart failure and a reduced ejection fraction.

August 28, 2020

The system maintains tight glucose control and reduces the risk of hypoglycemia.

August 14, 2020

A single nucleotide polymorphism is associated with severe and proliferative retinopathy risk reduction by 42% and 63%, respectively.

August 12, 2020

Treatment with the PCSK9 Inhibitor did not increase risk of safety events, including new-onset diabetes.

August 05, 2020

Older, white patients and those who use linagliptin are at a higher risk of bullous pemphigoid.